Upstream Bio, Inc.
UPB
$17.63
-$0.11-0.62%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 22.60% | -2.94% | -0.42% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.60% | -2.94% | -0.42% | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 22.60% | -2.94% | -0.42% | -- | -- |
| SG&A Expenses | 74.98% | 66.12% | 60.52% | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 112.50% | 96.90% | 88.58% | -- | -- |
| Operating Income | -116.05% | -101.93% | -93.86% | -- | -- |
| Income Before Tax | -157.91% | -176.57% | -205.82% | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -157.91% | -176.57% | -205.82% | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -157.91% | -176.57% | -205.82% | -- | -- |
| EBIT | -116.05% | -101.93% | -93.86% | -- | -- |
| EBITDA | -116.01% | -101.93% | -93.93% | -- | -- |
| EPS Basic | 52.58% | 2.77% | -40.82% | -- | -- |
| Normalized Basic EPS | 48.23% | -15.39% | -103.31% | -- | -- |
| EPS Diluted | 52.58% | 2.77% | -40.82% | -- | -- |
| Normalized Diluted EPS | 48.23% | -15.39% | -103.31% | -- | -- |
| Average Basic Shares Outstanding | 1,207.08% | 797.71% | 374.24% | -- | -- |
| Average Diluted Shares Outstanding | 1,207.08% | 797.71% | 374.24% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |